<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="3" ids="17754">Glycerol</z:chebi>, the end product of <z:chebi fb="0" ids="16247">phospholipid</z:chebi> degradation, was measured in cat brains under pathophysiological conditions known to cause activation of lipolysis, namely, <z:chebi fb="0" ids="3092">bicuculline</z:chebi>-induced <z:hpo ids='HP_0001250'>seizures</z:hpo>, permanent focal <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> (2 hr of middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp>), and global <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> (15 min of complete <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> with or without 2 hr of recirculation) </plain></SENT>
<SENT sid="1" pm="."><plain>In addition, ATP and <z:chebi fb="4" ids="24996">lactate</z:chebi> were measured in order to correlate the activation of <z:chebi fb="23" ids="18059">lipid</z:chebi> degradation with disturbances in the energy-producing metabolism </plain></SENT>
<SENT sid="2" pm="."><plain>A highly significant increase in the tissue <z:chebi fb="3" ids="17754">glycerol</z:chebi> content was observed after 1 hr of <z:chebi fb="0" ids="3092">bicuculline</z:chebi>-induced <z:hpo ids='HP_0001250'>seizures</z:hpo> (from 0.29 +/- 0.07 mumol/g in control animals to 1.30 +/- 0.06 mumol/g in <z:hpo ids='HP_0001250'>seizure</z:hpo> animals; P less than 0.001) or after 15 min of complete <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> (from 0.29 +/- 0.07 to 1.17 +/- 0.14 mumol/g; P less than 0.01) </plain></SENT>
<SENT sid="3" pm="."><plain>Furthermore, a close correlation was found between the increase in <z:chebi fb="3" ids="17754">glycerol</z:chebi> and the increase in <z:chebi fb="4" ids="24996">lactate</z:chebi> or decrease in ATP after permanent focal <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>In contrast, following recirculation after complete <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo>, restoration of the energy pool did not lead to a reduction of the <z:chebi fb="3" ids="17754">glycerol</z:chebi> formed during <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>It is concluded that <z:chebi fb="3" ids="17754">glycerol</z:chebi> is a useful indicator of <z:chebi fb="23" ids="18059">lipid</z:chebi> degradation under pathological conditions </plain></SENT>
<SENT sid="6" pm="."><plain>Since <z:chebi fb="3" ids="17754">glycerol</z:chebi> formed during <z:e sem="disease" ids="C1096458" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">vascular occlusion</z:e> is trapped in brain cells, presumably owing to low <z:chebi fb="3" ids="17754">glycerol</z:chebi> kinase activity, it can be used as a stable postischemic indicator of <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>-induced <z:chebi fb="23" ids="18059">lipid</z:chebi> degradation </plain></SENT>
</text></document>